Ensysce Biosciences (ENSCW) Debt to Equity (2019 - 2022)
Ensysce Biosciences (ENSCW) reported Debt to Equity of -$0.03 for Q4 2022, up 92.23% year-over-year from -$0.02 in Q4 2021, and up 89.79% quarter-over-quarter from -$0.34 in Q3 2022.
Ensysce Biosciences (ENSCW) Debt to Equity (2019 - 2022) Analysis & Trends
Ensysce Biosciences (ENSCW) has 4 years of Debt to Equity data on file, last reported at -$0.03 in Q4 2022.
- Debt to Equity for Q4 2022 came in at -$0.03, up 92.23% year-over-year; the trailing twelve-month figure through Dec 2022 was -$0.03 (up 92.23% YoY), and the FY2022 annual result was -$0.03, up 92.23% from the prior year.
- Debt to Equity grew to -$0.03 in Q4 2022 per ENSCW's latest filing, from -$0.34 in the prior quarter.
- Over five years, Debt to Equity peaked at $1.43 in Q1 2022 and troughed at -$5.49 in Q3 2021.
- A 4-year average of -$0.49 and a median of -$0.08 in 2020 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2021 and 2022: Debt to Equity plunged 6427.62% in 2021, then surged 93.79% in 2022.
- A 4-year view of Debt to Equity shows it stood at $0.01 in 2019, then plunged by 843.68% to -$0.09 in 2020, then slumped by 426.47% to -$0.45 in 2021, then surged by 92.23% to -$0.03 in 2022.
- Business Quant data shows ENSCW's Debt to Equity at -$0.03 in Q4 2022, -$0.34 in Q3 2022, and -$0.17 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -0.03 |
| Sep 30, 2022 | -0.34 |
| Jun 30, 2022 | -0.17 |
| Mar 31, 2022 | 1.43 |
| Dec 31, 2021 | -0.45 |
| Sep 30, 2021 | -5.49 |
| Dec 31, 2020 | -0.09 |
| Sep 30, 2020 | -0.08 |
| Jun 30, 2020 | -0.07 |
| Mar 31, 2020 | -0.07 |
| Dec 31, 2019 | 0.01 |